Senior Manager, Financial Reporting at Acadia Pharmaceuticals

Waltham, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, PharmaceuticalIndustries

Requirements

Bachelor’s degree in accounting or related field; CPA designation strongly preferred
7+ years of experience in public accounting and/or SEC reporting and consolidations in a public company (Mix of Big 4 and industry experience preferred)
Experience with NetSuite and SEC reporting platform Workiva a plus
Experience with CPM tools (e.g. OneStream, DataRails, Hyperion)
Strong understanding of US GAAP, SEC regulations, and financial reporting requirements
Excellent analytical and problem-solving skills
Effective communication and collaboration skills with the ability to interact with cross-functional teams and external stakeholders
Ability to provide clear explanations of accounting matters to team members of all levels
Self-motivated

Responsibilities

Prepare reporting packages for financial statements and internal reporting
Assist in the preparation and filing of quarterly and annual reports on Forms 10-Q and 10-K, respectively, in accordance with SEC regulations
Prepare the consolidated cash flow statement
Lead the monthly and quarterly consolidation tasks of Madrigal’s 10+ legal entities (multi-currency), including preparing and managing top-side journal entries
Oversee global intercompany eliminations entries
Manage global chart of accounts and financial statement line-item mappings in DataRails
Ensure appropriate integration and connection of DataRails with Madrigal’s ERP systems
Continuously enhance the close and financial reporting processes to improve efficiency, accuracy, and internal controls
Contribute to the financial close, as needed, as reviewer of reconciliations or preparer of memos / workpapers for complex accounting transactions
Stay current on new accounting standards and SEC rules and regulations, implementing changes to reporting processes as necessary
Assist with the implementation of new accounting standards and miscellaneous accounting-related projects (e.g. business development and M&A projects, etc.)
Coordinate with internal and external auditors
Coach other team members on accounting matters and provide exposure to staff on areas within SEC reporting to expand the team’s skillsets

Skills

Key technologies and capabilities for this role

Financial ReportingSEC Reporting10-Q10-KFinancial ConsolidationsCash Flow StatementsGAAPAccounting StandardsFinancial Statements

Questions & Answers

Common questions about this position

What is the work arrangement for this position?

The role is hybrid and based from Waltham, MA.

What are the key responsibilities of the Senior Manager, Financial Reporting?

Key responsibilities include preparing reporting packages for financial statements, assisting with SEC filings like Forms 10-Q and 10-K, leading monthly and quarterly consolidations of 10+ entities, overseeing intercompany eliminations, and managing DataRails integration with ERP systems.

What salary or compensation is offered for this role?

This information is not specified in the job description.

What is the company culture like at Madrigal?

Madrigal is building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration.

What experience makes a strong candidate for this position?

Strong candidates will have expertise in SEC reporting, financial consolidations across multiple entities and currencies, proficiency with tools like DataRails and ERP systems, and knowledge of accounting standards, with the ability to coach team members and improve processes.

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free